AU6616400A - Hiv integrase inhibitors - Google Patents

Hiv integrase inhibitors

Info

Publication number
AU6616400A
AU6616400A AU66164/00A AU6616400A AU6616400A AU 6616400 A AU6616400 A AU 6616400A AU 66164/00 A AU66164/00 A AU 66164/00A AU 6616400 A AU6616400 A AU 6616400A AU 6616400 A AU6616400 A AU 6616400A
Authority
AU
Australia
Prior art keywords
hiv integrase
integrase inhibitors
inhibitors
hiv
integrase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU66164/00A
Inventor
Anne Dombrowski
Daria Hazuda
Fernando Pelaez
Jon D Polishook
Sheo Singh
Ana Teran
Deborah L. Zink
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of AU6616400A publication Critical patent/AU6616400A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/14—Fungi; Culture media therefor
    • C12N1/145—Fungal isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/181—Heterocyclic compounds containing oxygen atoms as the only ring heteroatoms in the condensed system, e.g. Salinomycin, Septamycin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/645—Fungi ; Processes using fungi

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU66164/00A 1999-08-03 2000-07-31 Hiv integrase inhibitors Abandoned AU6616400A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US14699499P 1999-08-03 1999-08-03
US60146994 1999-08-03
PCT/US2000/020918 WO2001009114A1 (en) 1999-08-03 2000-07-31 Hiv integrase inhibitors

Publications (1)

Publication Number Publication Date
AU6616400A true AU6616400A (en) 2001-02-19

Family

ID=22519915

Family Applications (1)

Application Number Title Priority Date Filing Date
AU66164/00A Abandoned AU6616400A (en) 1999-08-03 2000-07-31 Hiv integrase inhibitors

Country Status (3)

Country Link
US (1) US6245806B1 (en)
AU (1) AU6616400A (en)
WO (1) WO2001009114A1 (en)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1274459B1 (en) * 2000-04-19 2005-11-16 Genentech, Inc. Sustained release formulations comprising growth hormone
US7318931B2 (en) * 2001-06-21 2008-01-15 Genentech, Inc. Sustained release formulation
US7157489B2 (en) * 2002-03-12 2007-01-02 The Board Of Trustees Of The University Of Illinois HIV protease inhibitors
JP2004055646A (en) 2002-07-17 2004-02-19 Sumitomo Electric Ind Ltd P-side electrode structure of light-emitting diode element
US7049394B2 (en) * 2002-08-19 2006-05-23 Rohm And Haas Company Method for preparing free flow resin
AU2003301439A1 (en) 2002-10-16 2004-05-04 Gilead Sciences, Inc. Pre-organized tricyclic integrase inhibitor compounds
US7986742B2 (en) 2002-10-25 2011-07-26 Qualcomm Incorporated Pilots for MIMO communication system
PA8586801A1 (en) 2002-10-31 2005-02-04 Pfizer HIV-INTEGRESS INHIBITORS, PHARMACEUTICAL COMPOSITIONS AND METHODS FOR USE
EP1664046B1 (en) 2003-09-19 2009-06-17 Gilead Sciences, Inc. Aza-quinolinol phosphonate integrase inhibitor compounds
US20080153783A1 (en) * 2004-01-12 2008-06-26 Gilead Sciences, Inc. Pyrimidyl Phosphonate Antiviral Compounds and Methods of Use
EP1711476A2 (en) * 2004-01-12 2006-10-18 Gilead Sciences, Inc. Pyrimidyl phosphonate antiviral compounds and methods of use
AU2005249363A1 (en) * 2004-04-14 2005-12-15 Zhenhong R. Cai Phosphonate analogs of HIV integrase inhibitor compounds
WO2005103003A2 (en) 2004-04-26 2005-11-03 Pfizer Inc. Pyrrolopyridine derivatives and their use as hiv-integrase inhibitors
EP1873155A1 (en) * 2004-04-26 2008-01-02 Pfizer Inc. Inhibitors of the HIV integrase enzyme
MXPA06012342A (en) * 2004-04-26 2007-01-17 Pfizer Inhibitors of the hiv integrase enzyme.
AR057023A1 (en) * 2005-05-16 2007-11-14 Gilead Sciences Inc HETEROCICLICAL COMPOUNDS WITH HIV-INTEGRASA INHIBITING PROPERTIES
WO2007136714A2 (en) * 2006-05-16 2007-11-29 Gilead Sciences, Inc. Integrase inhibitors
NZ575831A (en) 2006-09-29 2011-12-22 Idenix Pharmaceuticals Inc Enantiomerically pure phosphoindoles as hiv inhibitors
EP2254582B1 (en) 2008-01-25 2016-01-20 Chimerix, Inc. Methods of treating viral infections
US8283366B2 (en) 2010-01-22 2012-10-09 Ambrilia Biopharma, Inc. Derivatives of pyridoxine for inhibiting HIV integrase
WO2011100698A2 (en) 2010-02-12 2011-08-18 Chimerix, Inc. Methods of treating viral infection
US20130115237A1 (en) 2010-06-09 2013-05-09 Vaccine Technologies, Incorporated Therapeutic immunization in hiv infected subjects to augment antiretroviral treatment
CN113480557B (en) * 2021-09-06 2021-11-09 广东省科学院微生物研究所(广东省微生物分析检测中心) Polyketone compounds, preparation method thereof and application thereof in preparation of antitumor drugs

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2409992A (en) * 1991-08-08 1993-03-02 Tsumura & Co. Carcinostatic compound and production thereof
WO1995003311A1 (en) * 1993-07-19 1995-02-02 Xuande Luo Qinghaosu derivatives against aids

Also Published As

Publication number Publication date
US6245806B1 (en) 2001-06-12
WO2001009114A1 (en) 2001-02-08

Similar Documents

Publication Publication Date Title
AU6616400A (en) Hiv integrase inhibitors
AU2003248872A1 (en) Hiv integrase inhibitors
AU2002211874A1 (en) Aza- and polyaza-naphthalenyl carboxamides useful as hiv integrase inhibitors
AU3118200A (en) Hiv integrase inhibitors
AU4198500A (en) Suture-passing forceps
AU2400101A (en) Laser hair-remover
AU6143700A (en) Split-key key-agreement protocol
AU4340900A (en) Devices
PL370664A1 (en) Hiv integrase inhibitors
EP1086091A4 (en) Hiv integrase inhibitors
AU8009900A (en) Hiv integrase inhibitors
AU6989501A (en) Hiv integrase inhibitors
AU1408300A (en) Hiv infection inhibitors
AU2002349675A1 (en) Derivative having hiv integrase inhibitory activity
AU5460800A (en) Pharmaceutical transdermal compositions
AU6062700A (en) Devices
AU3235100A (en) Prothease inhibitors
AU1533601A (en) Hollow-needle devices
AU5833400A (en) Peroxide-based antimalarial compounds
AUPQ488899A0 (en) Scaffolding
AU7957000A (en) Cyclooxygenase-2 expression inhibitors
AU3080301A (en) Hoist
AU6271098A (en) Hiv integrase inhibitors
AU3714800A (en) Hiv therapy
AU6062600A (en) Devices

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase